[1]
M. Kusunoki, “The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes”, J Endocrinol Metab, vol. 16, no. 3, pp. 142–147, Jan. 2026, doi: 10.14740/jem1637.